NEOGENOMICS INC (NEO) earnings date
Feb 16, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 28 days, typically, give or take 9 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Wed, Oct 28, 2026 | after close | 28 | 8-K |
| Q2 FY2026 | Tue, Jul 28, 2026 | after close | 28 | 8-K |
| Q1 FY2026 | Tue, Apr 28, 2026 | after close | 28 | 8-K |
| Q4 FY2025 | Tue, Feb 17, 2026 | before open | 48 | 8-K |
| Q3 FY2025 | Tue, Oct 28, 2025 | before open | 28 | 8-K |
| Q2 FY2025 | Tue, Jul 29, 2025 | before open | 29 | 8-K |
| Q1 FY2025 | Tue, Apr 29, 2025 | before open | 29 | 8-K |
| Q4 FY2024 | Tue, Feb 18, 2025 | before open | 49 | 8-K |
What they guided beta
| Q3 FY2026 | "Document Exhibit 99.1 NeoGenomics Reports Third Quarter 2026 Results Total revenue increased 11% YoY to $209 million Clinical services revenue grew 13%, with NGS revenue growth of 29% Company raises full-year 2026 revenue and adjusted EBITDA guidance Fort Myers, Florida (October 28, 2026) - NeoGenomics, Inc. (NASDAQ: NEO) (the “ Company ” ), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its third-quarter results for the period ended September 30, 2026." exhibit |
| Q3 FY2026 | "See also the tables reconciling such measures to their closest GAAP equivalent. 2026 Financial Guidance The Company is revising its full-year 2026 guidance, as shown below (in millions)." exhibit |
| Q3 FY2026 | "FY 2025 Previous FY 2026 Guidance Updated FY 2026 Guidance YOY % Change from FY 2025 (in millions) Actual Low High Low High Low High Consolidated revenue $727 $802 $806 $807 $809 11% 11% Net loss $(108) $(42) $(34) $(32) $(30) 70% 72% Adjusted EBITDA $43 $56 $58 Approximately $60 Approximately 38% Conference Call The Company has scheduled a webcast and conference call to discuss its third quarter 2026 results on Wednesday , October 28, 2026 at 4:30 p.m. Eastern Time." exhibit |
| Q3 FY2026 | "The Company’s full-year 2026 guidance is based on management’s current expectations and assumptions as of the date of this press release." exhibit |
| Q2 FY2026 | "Document Exhibit 99.1 NeoGenomics Reports Second Quarter 2026 Results Total revenue increased 11% YoY to $202 million Clinical services revenue grew 14%, with NGS revenue growth of 26% Company raises full-year 2026 revenue and adjusted EBITDA guidance Fort Myers, Florida (July 28, 2026) - NeoGenomics, Inc. (NASDAQ: NEO) (the “ Company ” ), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced its second-quarter results for the period ended June 30, 2026." exhibit |
| Q2 FY2026 | "See also the tables reconciling such measures to their closest GAAP equivalent. 2026 Financial Guidance The Company is revising its full-year 2026 guidance, as shown below (in millions)." exhibit |
| Q2 FY2026 | "FY 2025 Previous FY 2026 Guidance Updated FY 2026 Guidance YOY % Change from FY 2025 (in millions) Actual Low High Low High Low High Consolidated revenue $727 $797 $803 $802 $806 10% 11% Net loss $(108) $(63) $(50) $(42) $(34) 61% 69% Adjusted EBITDA $43 $55 $57 $56 $58 29% 34% Conference Call The Company has scheduled a webcast and conference call to discuss its second quarter 2026 results on Tuesday , July 28, 2026 at 4:30 p.m. Eastern Time." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/NEO
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/NEO
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/NEO/"><img src="https://veritasdata.dev/embed/NEO.svg" alt="NEO earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/NEO/)
Script
<script async src="https://veritasdata.dev/embed/NEO.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/NEO"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.